DP
Deepa Pachoria
About Deepa Pachoria
Data last updated:
Deepa Pachoria is a Director at Nuken Pharmaceuticals Private Limited (since 2016). The companies operate in Non-Profit Organizations. Earlier, Deepa Pachoria was an Additional Director at Oaken Medicines Private Limited (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nuken Pharmaceuticals Private Limited U85300UP2016PTC083702 | Director | 31 May 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Oaken Medicines Private Limited U51397MP2014PTC032962 | Additional Director | 03 Mar 2016 | 2014 | ₹8.1 Lakh (FY 2016) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Deepa Pachoria
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chetan Kumar | 07458225 | Nuken Pharmaceuticals Private Limited | Director |
| Mool Chand Namdev | 06893891 | Nuken Pharmaceuticals Private Limited | Director |
| Suman Pachoria | 07458238 | Nuken Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepa Pachoria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepa Pachoria
Deepa Pachoria currently holds 1 directorship: Nuken Pharmaceuticals Private Limited (Director, since 31 May 2016).
Deepa Pachoria was first appointed on 03 Mar 2016 as Additional Director at Oaken Medicines Private Limited.
Deepa Pachoria held 1 earlier board appointment: Oaken Medicines Private Limited (Additional Director, from 03 Mar 2016).
The current boards of Deepa Pachoria's companies include Chetan Kumar (Nuken Pharmaceuticals Private Limited), Mool Chand Namdev (Nuken Pharmaceuticals Private Limited), Suman Pachoria (Nuken Pharmaceuticals Private Limited).